NanoXplore, Inc.TSX: GRA

Q1 (NanoXplore Q1 2027 FS Conso EN)

· Issued by NanoXplore, Inc.

Summary by 6ix AI

NanoXplore Inc., a graphene powder and graphene-enhanced products maker, had a loss of C$3,535,293 for the three months ended September 30, 2026, against C$3,776,330 a year earlier. Revenues from customers were C$31,160,777, against C$22,986,917. Amounts are unaudited.

Key details

  • Total revenues, including other income, were C$31,813,813 for the three months ended September 30, 2026, against C$23,442,651 for the three months ended September 30, 2025. The operating loss was C$3,186,882, against C$4,356,015.
  • Loss per share was C$0.02 (basic and diluted) in both periods. The weighted average share count was 181,487,392, against 170,608,431.
  • The Battery Cells and Materials segment had no revenues from customers in the three months ended September 30, 2026, against C$82,395 a year earlier.
  • For the three months ended September 30, 2026, operating activities provided C$1,533,767 of cash, against C$6,219,660 used in the same period a year earlier. Cash and cash equivalents were C$23,517,890 at September 30, 2026, against C$25,048,438 at June 30, 2026.
  • NanoXplore granted 200,000 stock options during the three months ended September 30, 2026, with exercise prices of C$1.37 and C$1.46.

6ix AI wrote this summary from the release below and checked it against the release.

NanoXplore Inc.

UNAUDITED CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

For the three-month periods ended September 30, 2026 and 2025 Consolidated Statements of Financial Position

(Unaudited - Expressed in Canadian dollars)

As at September 30,

2026

$

As at June 30,

2026

$

Assets

Current assets

Cash and cash equivalents

23,517,890

25,048,438

Accounts receivable and contract asset

27,960,000

33,057,368

Inventory

16,744,575

16,666,846

Prepaid expenses and other assets

1,997,555

1,650,236

70,220,020

76,422,888

Non-current assets

Lease deposits

303,317

303,114

Right-of-use assets [Note 3a]

20,313,859

18,546,208

Property, plant and equipment [Note 3b]

74,614,041

74,681,645

Intangible assets [Note 4]

10,524,747

10,935,678

Goodwill

1,919,673

1,919,673

Deferred tax assets

5,324,418

4,722,107

Total assets

183,220,075

187,531,313

Liabilities and Shareholders' Equity

Current liabilities

Operating loans

680,240

703,080

Accounts payable and accrued liabilities

18,623,245

20,509,619

Income taxes payable

243,340

82,759

Contract liability

594,383

441,636

Current portion of lease liability [Note 5]

5,369,328

4,896,438

Current portion of long-term debt [Note 5]

2,788,212

2,963,826

28,298,748

29,597,358

Non-current liabilities

Defined benefit liabilities

434,920

541,588

Lease liability [Note 5]

33,055,984

32,279,767

Long-term debt [Note 5]

7,032,006

7,590,609

Deferred tax liabilities

4,122,692

4,073,815

Total liabilities

72,944,350

74,083,137

Shareholders' equity

Share capital [Note 6]

207,510,956

207,510,956

Reserve

8,660,164

8,408,536

Foreign currency translation reserve

(361,989)

(382,374)

Deficit

(105,533,406)

(102,088,942)

Total shareholders' equity

110,275,725

113,448,176

Total liabilities and shareholders' equity

183,220,075

187,531,313

See accompanying notes to consolidated financial statements

Approved on behalf of the Board of Directors

Rocco Marinaccio

Rocco Marinaccio

Jos eph G. Peter

Joseph G. Peter

Consolidated Statements of Los s and Comprehensive Loss

Three-month periods ended September 30,

(Unaudited - Expressed in Canadian dollars)

2026

$

2025

$

Revenues

Revenues from customers Other income

31,160,777

653,036

22,986,917

455,734

31,813,813

23,442,651

Cost of sales and expenses

Cost of sales

24,397,364

19,021,547

Research and development expenses

1,172,336

1,211,423

Selling, general and administrative expenses

5,552,453

4,639,782

Share-based compensation expenses

251,628

204,546

Depreciation (production)

2,159,993

1,773,312

Depreciation (other)

703,823

707,635

Amortization

478,435

474,369

Foreign exchange

284,663

(233,948)

35,000,695

27,798,666

Operating loss

(3,186,882)

(4,356,015)

Interest on operating loans and long-term debt

(155,241)

(54,733)

Interest accretion on lease liability

(644,566)

(348,309)

Interest revenue

103,776

66,231

Loss before income taxes

(3,882,913)

(4,692,826)

Current income tax expense

(52,748)

(37,999)

Deferred income tax recovery

400,368

954,495

347,620

916,496

Loss

(3,535,293)

(3,776,330)

Other comprehensive income (loss)

Items that may be subsequently reclassified to profit and loss:

Exchange differences on translation of foreign subsidiaries

20,385

(192,193)

Items that will not be reclassified to profit and loss:

Retirement benefits - Net actuarial gain (loss)

90,829

132,105

Total comprehensive loss

(3,424,079)

(3,836,418)

Loss per share

Basic and diluted

(0.02)

(0.02)

Weighted average number of common shares outstanding (basic and diluted)

181,487,392

170,608,431

In light of the loss recognized for the periods, stock options were excluded from the calculation of diluted loss per share due to their anti-dilutive effect.

See accompanying notes to consolidated financial statements

Consolidated Statements of Changes in Shareholders' Equity

(Unaudited - Expressed in Canadian dollars)

Number of

common shares

Share capital

$

Reserve

$

Foreign currency

translation reserve

$

Deficit

$

Shareholders' equity

$

Balance as at June 30, 2025

170,608,431

182,683,203

7,290,752

95,323

(90,714,156)

99,355,122

Loss

-

-

-

-

(3,776,330)

(3,776,330)

Other comprehensive loss

-

-

-

(192,193)

132,105

(60,088)

Comprehensive loss

-

-

-

(192,193)

(3,644,225)

(3,836,418)

Exercise of stock options

-

Share-based compensation

-

-

204,546

-

-

204,546

Balance as at September 30, 2025

170,608,431

182,683,203

7,495,298

(96,870)

(94,358,381)

95,723,250

Loss

-

-

-

-

(8,051,651)

(8,051,651)

Other comprehensive income (loss)

-

-

-

(285,504)

321,090

35,586

Comprehensive loss

-

-

-

(285,504)

(7,730,561)

(8,016,065)

Private placement (net of issuing costs of $1,441,343)

10,720,350

24,287,497

-

-

-

24,287,497

Exercise of stock options

158,611

540,256

(186,256)

-

-

354,000

Share-based compensation

-

-

1,099,494

-

-

1,099,494

Balance as at June 30, 2026

181,487,392

207,510,956

8,408,536

(382,374)

(102,088,942)

113,448,176

Loss

-

-

-

-

(3,535,293)

(3,535,293)

Other comprehensive income

-

-

-

20,385

90,829

111,214

Comprehensive loss

-

-

-

20,385

(3,444,464)

(3,424,079)

Exercise of stock options

-

-

-

-

-

-

Share-based compensation

-

-

251,628

-

-

251,628

Balance as at September 30, 2026

181,487,392

207,510,956

8,660,164

(361,989)

(105,533,406)

110,275,725

See accompanying notes to consolidated financial statements

3

Consolidated Statements of Cash Flows

Three-month periods ended September 30,

(Unaudited - Expressed in Canadian dollars)

2026

$

2025

$

Cash flows from operating activities

Loss

(3,535,293)

(3,776,330)

Items not affecting cash:

Depreciation and amortization

3,342,251

2,955,316

Share-based compensation expenses

251,628

204,546

Interest accretion on lease liability

644,566

348,309

Interest accretion on long-term debt

8,489

14,478

Deferred income tax recovery

(400,368)

(954,495)

Difference between amounts paid for employee benefits and current year expenses

1,755

6,015

Net change in fair value of foreign exchange derivatives

52,482

530,386

Unrealized foreign exchange

(512,505)

(225,169)

Changes in non-cash operating working capital items:

Accounts receivable and contract asset

4,522,561

799,509

Inventory

(123,841)

(299,536)

Prepaid expenses and other assets

(351,719)

(364,969)

Accounts payable and accrued liabilities

(2,679,567)

(5,209,901)

Income taxes payable

160,581

17,734

Contract liability

152,747

(265,553)

1,533,767

(6,219,660)

Cash flows from financing activities

Variation of operating loans

-

(174,655)

Issuance of long-term debt

-

3,175,000

Repayment of lease liability

(1,959,512)

(1,078,322)

Repayment of long-term debt

(740,306)

(542,370)

(2,699,818)

1,379,653

Cash flows from investing activities

Additions to intangible assets

(52,797)

(542,361)

Additions to property, plant and equipment

(265,876)

(3,137,450)

(318,673)

(3,679,811)

Change in cash and cash equivalents

(1,484,724)

(8,519,818)

Net effect of currency exchange rate on cash

(45,824)

23,782

Cash and cash equivalents, beginning of year

25,048,438

18,587,960

Cash and cash equivalents, end of year

23,517,890

10,091,924

Interest on operating loans, long-term debt and lease liability paid

799,807

403,042

Additions to property, plant and equipment included in accounts payable and accrued liabilities

621,550

165,762

Additions to property, plant and equipment paid with equipment deposits

-

674,414

Investment tax credit recorded against the property, plant and equipment and included in accounts receivable and contract asset

242,977

-

See accompanying notes to consolidated financial statements

[Unaudited - Unless specified otherwise, amounts are expressed in Canadian dollars]

  1. NATURE OF OPERATIONS

    NanoXplore is a graphene company and the largest manufacturer and supplier of high-volume graphene powder for use in multiple end markets with up to 5,000 tonnes of annual production capacity. The Corporation also provides standard and custom graphene-enhanced plastic and composite products to customers in the recreational vehicle, transportation, packaging, electronics, and other industrial sectors, and manufactures silicon-graphene-enhanced Li-ion batteries for the energy storage, industrial, and defense markets. NanoXplore holds over 100 patents and patent applications protecting its intellectual property, products, and process knowledge, and is one of a limited number of companies authorized to produce and sell graphene at commercial scale in Canada, the United States, the United Kingdom, and the European Union, holding Environment and Climate Change Canada (ECCC) and Health Canada certification, U.S. EPA certification, and UK and EU REACH registrations.

    The Corporation was formed by amalgamation under the Canada Business Corporations Act by certificate of amalgamation dated September 21, 2017 and is headquartered at 4500 Thimens Blvd, Montreal, QC, Canada.

    NanoXplore is listed on the Toronto Stock Exchange ("TSX") and traded under "GRA" and is also listed on the OTCQX and traded under "NNXPF".

    The Corporation has two reportable segments based on products: Advanced Materials, Plastics and Composite Products and Battery Cells and Materials [Note 9].

    The unaudited condensed interim consolidated financial statements of the Corporation for the three-month periods ended September 30, 2026 and 2025 were reviewed, approved and authorized for issue by the Corporation's Board of Directors on November 10, 2026.

  2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of presentation

    The unaudited condensed interim consolidated financial statements of the Corporation and its subsidiaries for the three-month periods ended September 30, 2026 and 2025 have been prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board ("IFRS accounting standards"), and applicable to the preparation of interim financial statements including IAS 34, Interim Financial Reporting.

    These unaudited condensed interim consolidated financial statements are presented in Canadian dollars, the Corporation's functional currency, except where otherwise indicated. Each entity of the Corporation determines its own functional currency and items included in the financial statements of each entity are measured using that functional currency.

    The significant accounting judgments, estimates and assumptions used in these unaudited condensed interim consolidated financial statements are consistent with those disclosed in the most recent audited annual consolidated financial statements for the year ended June 30, 2026.

    These unaudited condensed interim consolidated financial statements have been prepared on a going concern basis, at historical cost, except for financial assets and liabilities classified as financial assets/liabilities at fair value through profit or loss and measured at fair value. Management considers that the fair value of financial assets and liabilities recorded in the financial statements approximates the carrying amount.

    Basis of consolidation

    The unaudited condensed interim consolidated financial statements include the accounts of the Corporation and its subsidiaries. The subsidiaries are using consistent accounting policies and the same reporting period as the parent company. All intercompany transactions, balances and unrealized gains or losses have been eliminated.

    The Corporation has the following subsidiaries:

    Subsidiaries

    Reporting segment

    CEBO Injections SA ("CEBO"), based in Switzerland, with an equity interest of 100% [2025 - 100%]

    Advanced Materials, Plastics and Composite Products

    NanoXplore Holdings USA, Inc. ("NanoXplore Holdings USA"), based in the United States, with an equity interest of 100% [2025 - 100%]. NanoXplore Holdings USA holds 100% of NanoXplore USA, Inc. and of RMC Advanced Technologies Inc. [2025 - 100%].

    Advanced Materials, Plastics and Composite Products

    Sigma Industries Inc. ("Sigma"), based in Canada, with an equity interest of 100% [2025 - 100%]. Sigma has two active wholly owned subsidiaries; Faroex Ltd., based in Manitoba, and Rene Composite Materials Ltd., based in Quebec. [2025 - 100%]

    Advanced Materials, Plastics and Composite Products

    Canuck Compounders Inc. ("Canuck"), [2025 - 100%]

    based in Canada,

    with an equity interest of 100%

    Advanced Materials,

    Plastics and Composite Products

    VoltaXplore Inc. ("VoltaXplore"), based in Canada, with an equity interest of 100% [2025 - 100%]

    Battery Materials

    Cells

    and

    Standards, interpretations and amendments to published standards adopted with an effect on the unaudited condensed interim consolidated financial statements

    The same accounting policies and methods of computation are followed in these unaudited condensed interim consolidated financial statements as compared with the most recent annual consolidated financial statements. The unaudited condensed interim consolidated financial statements should be read in conjunction with the audited annual consolidated financial statements and notes for the year ended June 30, 2026.

    For the three-month period ended September 30, 2026, the Management evaluated the new accounting standards and interpretations issued and effective under IFRS Accounting Standards and determined that they have no material impact on its consolidated financial statements.

    The following standards and amendments to existing standards have been published, and their adoption is mandatory for future accounting periods

    The IASB has issued new standards and amendments to existing standards which are applicable to the Corporation in future periods.

    IFRS 18 - Presentation and Dis clos ure in Financial Statements

    On April 9, 2024, the IASB issued IFRS 18 Presentation and Disclosure in Financial Statements to improve reporting of financial performance. IFRS 18 replaces IAS 1 Presentation of Financial Statements. It carries forward many requirements from IAS 1 unchanged. IFRS 18 applies for annual reporting periods beginning on or after January 1, 2027. Earlier application is permitted.

    The new Accounting Standard introduces significant changes to the structure of a corporation's income statement and new principles for aggregation and disaggregation of information. The main impacts of the new Accounting Standard include:

    • introducing a newly defined "operating profit" subtotal and a requirement for all income and expenses to be allocated between three distinct categories based on the company's main business activities: Operating, investing and financing;

    • disclosure about management performance measures; and,

    • adding new principles for aggregation and disaggregation of information.

    • requiring the cash flow statement to start with operating profit; and

    • removal of the accounting policy choice for presentation of dividend and interest. Management has not yet determined the impact, if any, for the Corporation.

  3. PROPERTY, PLANT AND EQUIPMENT AND RIGHT-OF-USE ASSETS

    Three-month

    period ended September 30, 2026

    $

    Year ended June 30, 2026

    $

    18,546,208

    6,130,403

    2,669,195

    15,209,899

    (911,753)

    (3,184,003)

    10,209

    389,909

    20,313,859

    18,546,208

    34,109,430

    31,430,026

    (13,795,571)

    (12,883,818)

    20,313,859

    18,546,208

    1. RIGHT-OF-USE ASSETS

Balance at the beginning

Additions Depreciation

Effect of foreign exchange differences

Balance at the end

Balance at the end

Cost

Accumulated amortization

Net book value

The majority of right-of-use assets are leases of land and building.

b) PROPERTY, PLANT AND EQUIPMENT

Land &

Production

Leasehold

Laboratory,

computer, office equipment and

Building

equipment

improvements

rolling stock

Total

$

$

$

$

$

Balance as at July 1, 2025

11,126,175

44,299,725

2,310,736

7,872,842

65,609,478

Additions

236,653

15,113,407

99,537

264,471

15,714,068

Disposals

-

-

-

-

-

Depreciation

(535,677)

(4,744,665)

(432,086)

(1,605,979)

(7,318,407)

Effect of foreign exchange differences

-

670,441

5,000

1,065

676,506

Balance as at June 30, 2026

10,827,151

55,338,908

1,983,187

6,532,399

74,681,645

Additions

37,114

917,558

33,785

179,117

1,167,574

Depreciation

(129,899)

(1,301,453)

(119,539)

(401,172)

(1,952,063)

Effect of foreign exchange differences

-

716,885

-

-

716,885

Balance as at September 30, 2026

10,734,366

55,671,898

1,897,433

6,310,344

74,614,041

As at June 30, 2026

Cost

13,845,677

83,253,963

4,330,739

13,732,514

115,162,893

Accumulated depreciation

(3,018,526)

(27,915,055)

(2,347,552)

(7,200,115)

(40,481,248)

Net book value

10,827,151

55,338,908

1,983,187

6,532,399

74,681,645

As at September 30, 2026

Cost

13,347,114

80,129,808

3,933,938

12,305,971

109,716,831

Accumulated depreciation

(2,612,748)

(24,457,910)

(2,036,505)

(5,995,627)

(35,102,790)

Net book value

10,734,366

55,671,898

1,897,433

6,310,344

74,614,041

The majority of property, plant and equipment is pledged as security for the credit facilities (Note 5).

Additions of production equipment under lease during the three-month period ended September 30, 2026 amounted to nil [year ended June 30, 2026 - $7,142,265].

As at September 30, 2026, there are $37,114, $2,797,745 and $507,894 of building, production equipment and computer. respectively, that are not yet available for use and for which depreciation has not started [As at June 30, 2026 - $206,298,

$7,866,462 and $492,554].

4.

INTANGIBLE ASSETS

Customer relationship

Technology

Patents, licenses and software

Total

$

$

$

$

Balance as at July 1, 2025

3,922,235

5,183,939

2,853,317

11,959,491

Additions

-

-

873,762

873,762

Amortization

(841,388)

(668,895)

(406,077)

(1,916,360)

Effect of foreign exchange differences

2,074

-

16,711

18,785

Balance as at June 30, 2026

3,082,921

4,515,044

3,337,713

10,935,678

Additions

-

-

52,797

52,797

Amortization

(210,135)

(167,224)

(101,076)

(478,435)

Effect of foreign exchange differences

(1,503)

-

16,210

14,707

Balance as at September 30, 2026

2,871,283

4,347,820

3,305,644

10,524,747

As at June 30, 2026

Cost

8,594,454

6,688,953

4,975,308

20,258,715

Accumulated depreciation

(5,511,533)

(2,173,909)

(1,637,595)

(9,323,037)

Net book value

3,082,921

4,515,044

3,337,713

10,935,678

As at September 30, 2026

Cost

8,592,951

6,688,953

5,044,315

20,326,219

Accumulated depreciation

(5,721,668)

(2,341,133)

(1,738,671)

(9,801,472)

Net book value

2,871,283

4,347,820

3,305,644

10,524,747

As at September 30, 2026, there is $104,895 of software that is not yet available for use and for which amortization has not started [As at June 30, 2026 - $91,961].

Maturity

Effective

interest rate

%

As at

September 30, 2026

$

As at

June 30, 2026

$

2026 to 2027

3.6%

680,240

703,080

2026 to 2035

2.4% to 8.4%

38,425,312

37,176,205

2027 to 2036

4.6% to 7.9%

9,820,218

10,554,435

48,925,770

48,433,720

680,240

703,080

5,369,328

4,896,438

2,788,212

2,963,826

40,087,990

39,870,376

  1. CREDIT FACILITIES Operating loans, fixed and variable rates

    - Authorized amount of $10,693,184

    Lease liability

    Long-term debt, fixed and variable rates

    Less: current portion of operating loans Less: current portion of lease liability Less: current portion of long-term debt

    Under these agreements, the Corporation has agreed to respect certain conditions and financial ratios. As at September 30, 2026, all conditions and financial ratios were met. Several movable hypothecs on specific assets of the Corporation and its subsidiaries and on the universality of the Corporation's present and future, tangible and intangible assets have been given as security for these long-term debt and credit facilities.

    1. LEASE LIABILITY

      As at September 30, 2026

      $

      As at June 30, 2026

      $

      14,357,644

      24,067,668

      15,145,046

      22,031,159

      38,425,312

      37,176,205

      The Corporation has the following leases related to equipment and building:

      Equipment [Note 3a, 3b] Building [Note 3a]

      Total lease liability

  2. EQUITY

    On October 30, 2025, the Corporation completed a financing by way of a bought deal private placement of 10,720,350 common shares at a price of $2.40 per share for gross proceeds of $25,728,840. The aggregate issuance costs related to this issuance, including the commission, were $1,441,343 and paid in cash.

    During the year ended June 30, 2026, 1,580,043 options were granted. These options have an exercise price between $2.09 and $2.43 with a vesting period between one year and three years and a half and expiration date between five and ten years from the grant date. The exercise price is based on the share price the day prior to the grant.

    During the year ended June 30, 2026, 158,611 options were exercised resulting in cash proceeds of $354,000 and a transfer from "Reserve" to "Share capital" of $186,256. The weighted average share price on the date of exercise of the options was

    $2.64.

    During the three-month period ended September 30, 2026, 200,000 options were granted. These options have an exercise price of $1.37 and $1.46 with a vesting period between one year and three years and a half and expiration date of ten years from the grant date. The exercise price is based on the share price the day prior to the grant.

  3. RELATED PARTY TRANSACTIONS

    Martinrea is a shareholder of the Corporation with significant influence. Subsidiaries of Martinrea purchased graphene-enhanced products and tooling products from the Corporation during the three-month period ended September 30, 2026 for an amount of

    $483,712 [As at June 30, 2026 - $533,794]. As at September 30, 2026, an amount of $290,656 due by Martinrea is included in Accounts receivable and contract assets [As at June 30, 2026 - $351,267].

  4. COMMITMENTS

    As at September 30, 2026, the Corporation held forward exchange contracts to sell for a minimum of US$10.0 million and a maximum of US$15.3 million depending on the exchange rate of such derivative contracts. Rates vary from 1.352 to up to 1.403. The contracts are valid until March 2028. As at September 30, 2026, the carrying value of the derivative foreign currency forward exchange contracts of $466,302 is included in Accounts payable and accrued liabilities [As at June 30, 2026 - $413,820].

  5. SEGMENTED DISCLOSURE

The Corporation's Chief Operating Decision Maker analyzes the information for the Corporation on two reporting segments, based on products:

  • Advanced Materials, Plastics and Composite Products:

    Provides standard and custom graphene-enhanced plastic and composite products to various customers in transportation, packaging, electronics, and other industrial sectors.

  • Battery Cells and Materials:

Provides silicon-graphene-enhanced Li-ion battery cells for the energy storage, industrial and defense markets.

The accounting policies of the segments are the same as the accounting policies of the Corporation.

Revenues and Expenses by operating segments

For the three-month periods ended September 30, 2026 and 2025:

2026

Advanced Materials, Plastics and Compos ite Products

$

2025

Battery Cells and Materials

$

Total

$

Advanced Materials,

Plastics and Battery

Compos ite Cells and

Products Materials

$ $

Total

$

Revenues

Revenues from customers

31,160,777

-

31,160,777

22,904,522

82,395

22,986,917

Other income

324,341

328,695

653,036

259,014

196,720

455,734

31,485,118

328,695

31,813,813

23,163,536

279,115

23,442,651

Cost of sales and expens es

Cost of sales

24,397,364

-

24,397,364

19,021,547

-

19,021,547

Research and development

expenses and Selling, general and

6,292,490

432,299

6,724,789

5,500,747

350,458

5,851,205

administrative expenses

Share-based compensation expenses

251,628

-

251,628

204,546

-

204,546

Depreciation and amortization

2,929,135

413,116

3,342,251

2,541,901

413,415

2,955,316

Foreign exchange

283,526

1,137

284,663

(230,948)

(3,000)

(233,948)

34,154,143

846,552

35,000,695

27,037,793

760,873

27,798,666

Operating loss

(2,669,025)

(517,857)

(3,186,882)

(3,874,257)

(481,758)

(4,356,015)

Net interest expenses

(687,297)

(8,734)

(696,031)

(329,957)

(6,854)

(336,811)

Loss before income taxes

(3,356,322)

(526,591)

(3,882,913)

(4,204,214)

(488,612)

(4,692,826)

Follow us

NanoXplore, Inc. on 6ix

Earlier from NanoXplore

All NanoXplore news releases